Prior Auth Required

81327 - SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysis

This procedure appears on the selected insurer prior authorization source.

Prior authorizationPrior Auth Required
Procedure / ServiceSEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysis
Procedure / Service Description

Genetic and Molecular Testing Medical Necessity Guideline - 81326 PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; known familial variant 81327 SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysis 81328 SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5)

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.